CSIMarket
 
Mckesson Corporation  (MCK)
Other Ticker:  
 
 
Price: $529.7100 $-3.93 -0.736%
Day's High: $536.68 Week Perf: -0.29 %
Day's Low: $ 528.56 30 Day Perf: 4.75 %
Volume (M): 570 52 Wk High: $ 537.26
Volume (M$): $ 301,723 52 Wk Avg: $435.16
Open: $532.44 52 Wk Low: $334.79



 Market Capitalization (Millions $) 70,610
 Shares Outstanding (Millions) 133
 Employees 75,000
 Revenues (TTM) (Millions $) 301,506
 Net Income (TTM) (Millions $) 3,156
 Cash Flow (TTM) (Millions $) -795
 Capital Exp. (TTM) (Millions $) 600

Mckesson Corporation
McKesson Corporation, is a Fortune 16 corporation providing supply, information and care management products and services designed to reduce costs and improve quality across the healthcare industry.

We conduct our business through three segments. Through our Pharmaceutical Solutions segment, we are a leading distributor of ethical and proprietary drugs, and health and beauty care products throughout North America. This segment also manufactures and sells automated pharmaceutical dispensing systems for hospitals and retail pharmacies, medical management and specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, patient and payor services, consulting and outsourcing services to pharmacies and distribution of first-aid products in the United States. Our Medical-Surgical Solutions segment distributes medical-surgical supplies and equipment, and provides logistics and related services within the United States. Our Information Solutions segment delivers enterprise-wide patient care, clinical, financial, supply chain, managed care and strategic management software solutions, as well as outsourcing and other services, to healthcare organizations throughout North America, the United Kingdom and other European countries. The Company's strategy is to create strong, value-based relationships with customers, enabling us to sell additional products and services to these customers over time.

The U.S. Pharmaceutical Distribution business operates and serves over 30,000 locations through a network of 28 distribution centers, as well as a master distribution center and a repackaging facility, serving all 50 states. We invest in technology and other systems at all of our distribution centers to enhance safety, reliability and the best product availability for our customers. For example, in all of our distribution centers we use Acumax' Plus, a Smithsonian award-winning technology, which integrates and tracks all internal functions, such as receiving, put-away and order fulfillment. Acumax' Plus uses bar code technology, wrist-mounted computer hardware, and radio frequency signals to provide our customers with industry leading order quality and fulfillment at up to 99.9% accuracy. Closed Loop DistributionSM, which integrates portable Palm technology with Acumax' Plus to give customers complete ordering and inventory control, and Supply Management OnlineSM, an Internet-based ordering, purchasing, third-party reconciliation and account management system, help ensure that our customers have the right products at the right time for their facilities and patients.

Competition

In every area of healthcare distribution operations, our Pharmaceutical Solutions and Medical-Surgical Solutions segments face strong competition, both in price and service, from national, regional and local full-line, short-line and specialty wholesalers, service merchandisers, self-warehousing chains, and manufacturers engaged in direct distribution. In addition, these segments face competition from various other service providers and from pharmaceutical and other healthcare manufacturers (as well as other potential customers of the segments) which may from time to time decide to develop, for their own internal needs, supply management capabilities which are provided by the segments and other competing service providers. Price, quality of service, and, in some cases, convenience to the customer are generally the principal competitive elements in these segments.

Our Information Solutions segment experiences substantial competition from many firms, including other computer services firms, consulting firms, shared service vendors, certain hospitals and hospital groups, hardware vendors and Internet-based companies with technology applicable to the healthcare industry. Competition varies in size from small to large companies, in geographical coverage, and in scope and breadth of products and services offered.



   Company Address: 6555 State Hwy 161 Irving 75039 TX
   Company Phone Number: 446-4800   Stock Exchange / Ticker: NYSE MCK
    Next quarterly dividend pay out on April 01, 2024.


Customers Net Income fell by MCK's Customers Net Profit Margin fell to

-1.34 %

2.96 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CAH   -4.72%    
CTSH   -2.59%    
DHR   -0.64%    
JNJ   -3.67%    
MDT   -2.43%    
MMM        6.16% 
• View Complete Report
   



Mckesson Corporation

Despite Strong Revenue, McKesson Corporation's Earnings Decline in Q3 2024

McKesson Corporation, a leading healthcare services company, has experienced a significant increase in its stock performance in recent months. Over the past three months, the company's stock has improved by 15.42%. However, during the month of February, the stock dropped by 2.94%. Despite this dip, McKesson Corporation's stock has reached its 52-week high.
One of the factors contributing to the fluctuation in McKesson Corporation's stock price is its financial performance. In the third quarter of the 2024 earnings season, the company experienced a decline in earnings per share (EPS) while revenue increased. EPS plummeted by -42.3% to $4.42 per share, while revenue showed an admirable increase of 14.765% to $80.90 billion compared to the same reporting season the previous year.

Dividend

McKesson Corporation Declares Quarterly Dividend, Reflecting Steady Growth and Investor Confidence

Published Thu, Feb 1 2024 1:00 PM UTC



In a recent press release, the McKesson Corporation, a prominent healthcare services leader, announced the declaration of a regular dividend of 62 cents per share of common stock. The dividend is scheduled to be payable on April 1, 2024, to stockholders of record on March 1, 2024. This development comes as McKesson Corporation continues to showcase remarkable growt...

Merger and Acquisition

McKesson Corporation is scheduled to present at the 42nd Annual JP Morgan Healthcare Conference today, where the executive leadership will provide an overview of the company followed by a fireside chat This event will take place at the Westin St Francis Hotel in San Francisco at 9:45 AM PT (12:45 PM ET) Those interested can tune into the audio webcast live at McKesson's Investor Relations website, investormckessoncom, where the company's slide presentation will also be available

Published Tue, Jan 9 2024 1:00 PM UTC

McKesson Corporation is scheduled to present at the 42nd Annual J.P. Morgan Healthcare Conference today, where the executive leadership will provide an overview of the company followed by a fireside chat. This event will take place at the Westin St. Francis Hotel in San Francisco at 9:45 AM PT (12:45 PM ET). Those interested can tune into the audio webcast live at McKesson's...

Mckesson Corporation

Dismal Fiscal Q2 2024 Results Unveil a Harsh -23.36% Deterioration in EPS at McKesson Corporation

Financial News Report: McKesson Corporation Reports Contractions in EPS Despite Revenue Increase in Fiscal Q2 2024
McKesson Corporation, a Pharmacy Services & Retail Drugstore company, experienced a contraction in earnings per share (EPS) in the fiscal second quarter of 2024, despite an elevation in revenue. Income fell by -23.36% to $4.92 per share, while revenue increased significantly by 10.06% to $77.22 billion, compared to the same reporting period a year ago.
In terms of revenue, McKesson Corporation has surpassed its sector contemporaries, as the remainder of the Pharmacy Services & Retail Drugstore sector reported a top-line elevation of only 9.43% in the same period. In comparison to the preceding reporting period, income dropped by -29.91% from $7.02 per share, while revenue grew by 3.668% from $74.48 billion.

Dividend

McKesson Corporation Continues to Drive Growth and Delight ShareholdersNote: The actual title may be subject to modification to align with the editorial guidelines and style of the Wall Street Journal.

Published Thu, Oct 26 2023 12:00 PM UTC


Outline:

- McKesson Corporation declares a regular dividend of 62 cents per share of common stock.
- Payable on January 2, 2024, to stockholders of record on December 1, 2023.
- Overview of McKesson Corporation as a diversified healthcare services leader.
Increasing Earnings and Dividend Pay-out:
- McKesson Corporation showcases rising earnings ...






 

Mckesson's Segments
 
U.S. Healthcare direct distribution & services
 Segment     of total Revenue
Canada distribution & services
 Segment     of total Revenue
Pharmaceutical Solutions
 Segment     of total Revenue
Medical-Surgical Solutions
 Segment     of total Revenue
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Mckesson does not provide revenue guidance.

Earnings Outlook
Mckesson Corporation issued annual earnings guidance on

 
Geographic Revenue Dispersion
United States
International




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com